Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 28:9:960768.
doi: 10.3389/fsurg.2022.960768. eCollection 2022.

Enucleation versus hepatectomy for hepatic hemangiomas: A meta-analysis

Bin Jiang  1 , Zheng-Chao Shen  1 , Xiao-San Fang  1 , Xiao-Ming Wang  1
Affiliations
Review

Enucleation versus hepatectomy for hepatic hemangiomas: A meta-analysis

Bin Jiang et al. Front Surg. .

Abstract

Objective: To compare the safety and efficacy of enucleation and hepatectomy for the treatment of hepatic hemangioma (HH).

Methods: A systematic literature search was conducted to identify studies evaluating enucleation versus hepatectomy for HH starting from the time of database creation to February 2022. Extraction of the data used in this study was done from the literature. The differences between the two surgical approaches were evaluated by comparing and analyzing the relevant data by means of meta-analysis.

Results: A total of 1,384 patients (726 underwent enucleation, and 658 with hepatectomy) were included in our meta-analysis from 12 studies. Enucleations were associated with favorable outcomes in terms of operation time [mean difference (MD): -39.76, 95% confidence interval (CI): -46.23, -33.30], blood loss (MD: -300.42, 95% CI: -385.64, -215.19), length of hospital stay (MD: -2.33, 95% CI: -3.22, -1.44), and postoperative complications (OR: 0.57, 95% CI: 0.44-0.74). There were no differences between the groups in terms of patients needing transfusion (OR: 0.85, 95% CI: 0.50, 1.42), inflow occlusion time (MD: 1.72, 95% CI: -0.27, 3.71), and 30-day postoperative mortality (OR: 0.23, 95% CI: 0.02-2.17).

Conclusion: Compared with hepatectomy, enucleation is found to be effective at reducing postoperative complications, blood loss, and operation time and shortening the length of hospital stay. Enucleation is similar to hepatectomy in terms of inflow occlusion time, 30-day postoperative mortality, and patients needing transfusing to hepatectomy.

Keywords: enucleation; hepatectomy; hepatic hemangiomas; meta-analysis; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flowchart.
Figure 2
Figure 2
The forest plots for operative outcomes in enucleation versus hepatectomy for HH.
Figure 3
Figure 3
The forest plots for postoperative outcomes in enucleation versus hepatectomy for HH.
Figure 4
Figure 4
The forest plot for tumor size in enucleation versus hepatectomy for HH.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the management of benign liver tumours. J Hepatol. (2016) 65:386–98. 10.1016/j.jhep.2016.04.001 - DOI - PubMed
    1. Liu Z, Yi L, Chen J, Li R, Liang K, Chen X, et al. Comparison of the clinical and MRI features of patients with hepatic hemangioma, epithelioid hemangioendothelioma, or angiosarcoma. BMC Med Imaging. (2020) 20:71. 10.1186/s12880-020-00465-4 - DOI - PMC - PubMed
    1. Macdonald A, Durkin N, Deganello A, Sellars ME, Makin E, Davenport M. Historical and contemporary management of infantile hepatic hemangioma: a 30-year single-center experience. Ann Surg. (2022) 275:e250–e5. 10.1097/SLA.0000000000003881 - DOI - PubMed
    1. Demircan O, Demiryurek H, Yagmur O. Surgical approach to symptomatic giant cavernous hemangioma of the liver. Hepatogastroenterology. (2005) 52:183–6. - PubMed
    1. Okano H, Shiraki K, Inoue H, Ito T, Yamanaka T, Deguchi M, et al. Natural course of cavernous hepatic hemangioma. Oncol Rep. (2001) 8:411–4. 10.3892/or.8.2.411 - DOI - PubMed

LinkOut - more resources